Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications.

Antibodies to cholinergic receptor structures were found in 75% of 76 Finnish and 93% of 175 Swedish patients with myasthenia gravis. The amount of antibodies showed a positive correlation to the severity of the disease, and was reduced during immunosuppressive treatment, and by thymectomy. Thymoma patients had high values. The antibody was also found in the cerebrospinal fluid. Two healthy newborn babies of myasthenic mothers had antibodies during the first weeks of life, in spite of no clinical symptoms. The occurrence of IgM antibodies before IgM antibodies in two patients during the early stages of myasthenia gravis suggests that the antibody is not a primary cause of the disease.

[1]  J. Simpson.  Myasthenia Gravis: A New Hypothesis , 1960 .

[2]  R. Pirskanen,et al.  ACETYLCHOLINE-RECEPTOR ANTIBODIES IN CEREBROSPINAL FLUID OF PATIENTS WITH MYASTHENIA GRAVIS , 1977, The Lancet.

[3]  L. Hammarström,et al.  EFFECTS OF SOME IMMUNOSUPPRESSIVE PROCEDURES ON MYASTHENIA GRAVIS * , 1976, Annals of the New York Academy of Sciences.

[4]  S. Fuchs,et al.  HUMORAL ANTIBODIES TO ACETYLCHOLINE RECEPTOR IN PATIENTS WITH MYASTHENIA GRAVIS , 1975, The Lancet.

[5]  E. Stålberg,et al.  Single Fibre EMG and Microphysiology of the Motor Unit in Normal and Diseased Human Muscle , 1973 .

[6]  A. Lefvert,et al.  Immunoglobulins in myasthenia gravis: effect of human lymph IgG 3 and F(ab‘)2 fragments on a cholinergic receptor preparation from Torpedo marmorata * , 1977, European journal of clinical investigation.

[7]  G. Matell,et al.  The effect of thoracic duct lymph drainage in myasthenia gravis. , 1973, European neurology.

[8]  C G Andrew,et al.  Serum Globulin in Myasthenia Gravis: Inhibition of α-Bungarotoxin Binding to Acetylcholine Receptors , 1974, Science.

[9]  J. Lindstrom.  An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis. , 1977, Clinical immunology and immunopathology.

[10]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[11]  T. Waldmann,et al.  Intestinal lymphangiectasia: a protein-losing enteropathy with hypogammaglobulinemia, lymphocytopenia and impaired homograft rejection. , 1967, The Journal of clinical investigation.

[12]  E W Bough,et al.  Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. , 1977, The New England journal of medicine.

[13]  R. J. Johns,et al.  Studies in neuromuscular function. IV. Stimulating and depressant effects of acetylcholine and choline in patients with myasthenia gravis, and their relationship to the defect in neuromuscular transmission. , 1956, Bulletin of the Johns Hopkins Hospital.

[14]  A. Papatestas,et al.  Studies in myasthenia gravis , 1975, Neurology.

[15]  J. Lindstrom,et al.  Anti-acetylcholine receptor antibody in neonatal myasthenia gravis. , 1977, The New England journal of medicine.

[16]  R. Almon,et al.  Acetylcholine receptor antibodies in myasthenia gravis. , 1975, The New England journal of medicine.

[17]  F. Greenwood,et al.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. , 1963, The Biochemical journal.